ADH1B and metabolic dysfunction-associated steatotic liver disease: However, Vilar-Gomez et al. discovered that patients with NAFLD and ADH1B*2 (mutant allele) had a decreased risk of steatohepatitis and fibrosis, and this protective effect remained significant even after controlling for alcohol consumption status, age, sex, and BMI.